ACM
TNGX icon

ADAR1 Capital Management’s Tango Therapeutics TNGX Stock Holding History

ADAR1 Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
50,000
-90,021
-64% -$1.25M 0.06% 154
2025
Q4 		$1.24M Buy
+140,021
New +$1.21M 0.09% 122
2025
Q2 		– Sell
-41,346
Closed -$56.6K – 237
2025
Q1 		$56.6K Buy
+41,346
New +$102K 0.01% 178

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

ADAR1 Capital Management's TNGX Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Tango Therapeutics (TNGX) stake by 64% in Q1 2026, selling an estimated $1.25M and leaving 50,000 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #154.

ADAR1 Capital Management first reported a position in TNGX in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.24M in Q4 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • ADAR1 Capital Management held 50,000 shares of Tango Therapeutics worth $1.05M as of Q1 2026.
  • ADAR1 Capital Management sold 90,021 Tango Therapeutics shares in Q1 2026, an estimated $1.25M.
  • Tango Therapeutics made up 0.06% of ADAR1 Capital Management's portfolio in Q1 2026, its #154 holding.
  • ADAR1 Capital Management first reported a position in Tango Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • ADAR1 Capital Management's Tango Therapeutics position peaked at $1.24M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.